Khan H - Search Results

1

Demethyleneberberine, a potential therapeutic agent in neurodegenerative disorders: a proposed mechanistic insight.

Saklani P, Khan H, Singh TG, Gupta S, Grewal AK. Saklani P, et al. Among authors: khan h. Mol Biol Rep. 2022 Oct;49(10):10101-10113. doi: 10.1007/s11033-022-07594-9. Epub 2022 Jun 3. Mol Biol Rep. 2022. PMID: 35657450 Review.

2

Novel Targets Explored in the Treatment of Alcohol Withdrawal Syndrome.

Gupta A, Khan H, Kaur A, Singh TG. Gupta A, et al. Among authors: khan h. CNS Neurol Disord Drug Targets. 2021;20(2):158-173. doi: 10.2174/1871527319999201118155721. CNS Neurol Disord Drug Targets. 2021. PMID: 33213357 Review.

3

Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.

Thapa K, Khan H, Sharma U, Grewal AK, Singh TG. Thapa K, et al. Among authors: khan h. Life Sci. 2021 Feb 15;267:118975. doi: 10.1016/j.lfs.2020.118975. Epub 2020 Dec 31. Life Sci. 2021. PMID: 33387580 Review.

4

Pharmacological postconditioning: a molecular aspect in ischemic injury.

Khan H, Kashyap A, Kaur A, Singh TG. Khan H, et al. J Pharm Pharmacol. 2020 Nov;72(11):1513-1527. doi: 10.1111/jphp.13336. Epub 2020 Jul 28. J Pharm Pharmacol. 2020. PMID: 33460133 Review.

5

Therapeutic modulation of the phosphatidylinositol 3-kinases (PI3K) pathway in cerebral ischemic injury.

Khan H, Singh A, Thapa K, Garg N, Grewal AK, Singh TG. Khan H, et al. Brain Res. 2021 Mar 2:147399. doi: 10.1016/j.brainres.2021.147399. Online ahead of print. Brain Res. 2021. PMID: 33662337

6

Mechanistic insight on the role of leukotriene receptors in ischemic-reperfusion injury.

Khan H, Gupta A, Singh TG, Kaur A. Khan H, et al. Pharmacol Rep. 2021 Oct;73(5):1240-1254. doi: 10.1007/s43440-021-00258-8. Epub 2021 Apr 5. Pharmacol Rep. 2021. PMID: 33818747 Review.

7

Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease.

Khan H, Tiwari P, Kaur A, Singh TG. Khan H, et al. Mol Neurobiol. 2021 Aug;58(8):3903-3917. doi: 10.1007/s12035-021-02387-w. Epub 2021 Apr 20. Mol Neurobiol. 2021. PMID: 33877561

8

Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets.

Thapa K, Khan H, Singh TG, Kaur A. Thapa K, et al. Among authors: khan h. J Mol Neurosci. 2021 Sep;71(9):1725-1742. doi: 10.1007/s12031-021-01841-7. Epub 2021 May 6. J Mol Neurosci. 2021. PMID: 33956297 Review.

9

Pharmacological Modulation of Ubiquitin-Proteasome Pathways in Oncogenic Signaling.

Sharma A, Khan H, Singh TG, Grewal AK, Najda A, Kawecka-Radomska M, Kamel M, Altyar AE, Abdel-Daim MM. Sharma A, et al. Among authors: khan h. Int J Mol Sci. 2021 Nov 4;22(21):11971. doi: 10.3390/ijms222111971. Int J Mol Sci. 2021. PMID: 34769401 Free PMC article. Review.

10

Neuropeptides: Potential neuroprotective agents in ischemic injury.

Saklani P, Khan H, Gupta S, Kaur A, Singh TG. Saklani P, et al. Among authors: khan h. Life Sci. 2022 Jan 1;288:120186. doi: 10.1016/j.lfs.2021.120186. Epub 2021 Nov 28. Life Sci. 2022. PMID: 34852271 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,911 results

Search Page

Filters